Immunocore Holdings plc
IMCRNasdaqCIK 1671927HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1411:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001671927-26-000026 |
| 2026-08-0611:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001671927-26-000022 |
| 2026-08-0611:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001671927-26-000020 |
| 2026-05-2720:21 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-022984 |
| 2026-05-0611:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019205 |
| 2026-05-0611:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001671927-26-000009 |
| 2026-04-1620:05 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001140361-26-015122 |
| 2026-02-2512:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-006721 |
| 2026-02-2512:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001671927-26-000005 |
| 2026-01-3012:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-002894 |
| 2026-01-0912:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-000780 |
| 2025-11-2812:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-043600 |
| 2025-11-0612:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-040664 |
| 2025-11-0612:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001671927-25-000018 |
| 2025-08-0711:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-029350 |
| 2025-08-0711:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001671927-25-000014 |
| 2025-05-1520:12 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-019282 |
| 2025-05-0711:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017615 |
| 2025-05-0711:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001671927-25-000009 |
| 2025-04-0410:05 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001140361-25-012123 |
| 2025-03-1712:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-008918 |
| 2025-03-1020:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-007867 |
| 2025-02-2612:22 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005988 |
| 2025-02-2612:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001671927-25-000006 |
| 2025-01-1021:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000837 |
| 2025-01-0212:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000008 |
| 2024-11-0821:20 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-24-045855 |
| 2024-11-0612:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045343 |
| 2024-11-0612:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001671927-24-000011 |
| 2024-09-1610:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-041100 |
| 2024-08-2911:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-039083 |
| 2024-08-0811:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036283 |
| 2024-08-0811:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001671927-24-000005 |
| 2024-05-3120:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-028366 |
| 2024-05-3021:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-028194 |
| 2024-05-2820:17 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-027667 |
| 2024-05-2320:50 ET | 8-K | 5.07 Shareholder vote results | 0001140361-24-027312 |
| 2024-05-0811:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-024789 |
| 2024-05-0811:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001140361-24-024784 |
| 2024-04-1220:20 ET | DEF 14A | Proxy statementPeriod 2024-05-23 | 0001140361-24-019623 |
| 2024-04-0520:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-018342 |
| 2024-03-0702:45 ET | SC 13D/A | Ownership report, active investor, amended | 0000950142-24-000652 |
| 2024-02-2821:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-010098 |
| 2024-02-2812:33 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001140361-24-009921 |
| 2024-02-0221:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-005309 |
| 2024-02-0122:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-009526 |
| 2024-01-2922:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-004321 |
| 2024-01-0512:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-000832 |
| 2024-01-0211:25 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-24-000012 |
| 2023-11-0712:09 ET | 6-K | Report of a foreign private issuerPeriod 2023-11-07 | 0001140361-23-051708 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.